Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
79 hedge funds and large institutions have $86M invested in Gritstone bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 15 closing their positions.
31% more call options, than puts
Call options by funds: $374K | Put options by funds: $285K
30% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 23
1% more capital invested
Capital invested by funds: $85.1M → $86M (+$870K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 87 → 79 (-8)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.92M |
| 2 |
Morgan Stanley
New York
|
+$2.45M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$588K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$346K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$341K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.33M |
| 2 |
Millennium Management
New York
|
-$2.54M |
| 3 |
Renaissance Technologies
New York
|
-$1.35M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$724K |
| 5 |
E
Ergoteles
New York
|
-$599K |
GRTS Hedge Fund Activity: Q3 2022 in Review
79 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2022, worth a combined $86M — up 1% from $85.1M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of GRTS and 7 opened new positions — a net loss of 8 holders — while 23 trimmed existing stakes and 30 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $2.92M. The largest seller was Deep Track Capital, cutting an estimated $5.33M.
- 79 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2022, down from 87 in Q2 2022.
- Funds reported $86M of Gritstone bio, Inc. Common Stock stock for Q3 2022, up 1% quarter-over-quarter.
- 7 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2022 and 15 closed out, a net change of -8 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $2.92M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q3 2022 was Deep Track Capital, an estimated $5.33M sold.
Based on aggregated 13F filings for Q3 2022.